tbuckley/cabot-search huggingface dataset:
HCK Transcription Is Regulated By AP1, NF-Kb and STAT3 Transcription Factors in MYD88 Mutated WM and ABC-DLBCL Cells
Authors: Xia Liu, Jiaji G Chen, Jie Chen, Lian Xu, Nicholas Tsakmaklis, Maria Demos, Christopher J Patterson, Jorge J. Castillo, Zachary Hunter, Steven P Treon, Guang Yang
Journal: Blood (2016)
The Role of Platelet Adhesion Receptor GPIb α Far Exceeds That of Its Main Ligand von Willebrand Factor in Arterial Thrombosis.
Authors: Wolfgang Bergmeier, Crystal L. Piffath, Tobias Goerge, Stephen M. Cifuni, Zaverio M. Ruggeri, Jerry Ware, Denisa D. Wagner
Journal: Blood (2006)
Prognostic Value of Antigen Expression in Multiple Myeloma (MM): A Large GEM/Pethema Study Based in Four Consecutive Clinical Trials
Authors: Bruno Paiva, Noemi Puig, Paula Arana, Teresa Cedena, Lourdes Cordon, Maria Belen Vidriales, Norma C Gutierrez, Joaquin Martinez-López, Miguel T Hernandez, Ana Isabel Teruel, Mercedes Gironella, M Asuncion Echeveste, Laura Rosiñol, Rafael Martinez, Albert Oriol, Javier De La Rubia, Joan Blade, Juan Jose Lahuerta, Maria-Victoria Mateos, Jesus San Miguel
Journal: Blood (2015)
Co-Administration of YM150, An Oral Direct Factor Xa Inhibitor, and Naproxen Does Not Result In Clinically Relevant Changes to the Pharmacodynamic or Pharmacokinetic Profile of Either Agent
Authors: Marten Heeringa, Alberto Garcia-Hernandez, Takeshi Kadokura, Dorien Groenendaal – van de Meent, Gregory Strabach, Roelof Mol, Charlotte Eltink, Hartmut Heinzerling
Journal: Blood (2010)
Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.
Authors: Jae Hoon Lee, Junshik Hong, Jin Seok Kim, June-Won Cheong, Cheolwon Suh, Kihyun Kim, Yang Soo Kim, Se-Ryeon Lee, Sung Hwa Bae, Young-Don Joo, Sang Min Lee, Hyeon Seok Eom, Eunkyung Park, Sung-Soo Yoon, Inho Kim, Jae-Yong Kwak, Chang-Ki Min, Jeong-A Kim, Moo-Rim Park, Sung Hyun Kim, Hye Jin Kang, Min Kyoung Kim, Hawk Kim, Yeung-Chul Mun, Hoon-Gu KIM, Moon Hee Lee
Journal: Blood (2012)
Safety, PK and preliminary efficacy of talazoparib in Japanese patients with advanced solid tumors; Phase 1 Study
Authors: Yoichi Naito, Yasutoshi Kuboki, Masafumi Ikeda, Kenichi Harano, Nobuaki Matsubara, Shigeyuki Toyoizumi, Masayo Oishi, Natsuki Hori, Takashi Nagasawa, Takahiro Kogawa
Journal: Annals of Oncology (2019)
A Phase I Study of INNO-406 in Patients with Advanced Philadelphia (Ph+) Chromosome-Positive Leukemias Who Are Resistant or Intolerant to Imatinib and Second Generation Tyrosine Kinase Inhibitors.
Authors: Hagop M. Kantarjian, Jorge Cortes, Philipp le Coutre, Arnon Nagler, Javier Pinilla, Andreas Hochhaus, Dan Jones, Adam R. Craig, Eileen Carroll, Oliver G. Ottmann
Journal: Blood (2007)
Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood–brain barrier dysfunction module
Authors: Roeben Nocon Munji, Allison Luen Soung, Geoffrey Aaron Weiner, Fabien Sohet, Bridgette Deanne Semple, Alpa Trivedi, Kayleen Gimlin, Masakazu Kotoda, Masaaki Korai, Sidar Aydin, Austin Batugal, Anne Christelle Cabangcala, Patrick Georg Schupp, Michael Clark Oldham, Tomoki Hashimoto, Linda J. Noble-Haeusslein, Richard Daneman
Journal: Nature Neuroscience (2019)
Integrative Analysis of MicroRNA and Gene Expression Profiling Contributes to Understand Mantle Cell Lymphoma Pathogenesis.
Authors: Lorena Di Lisio, Gonzalo Gómez-López, Margarita Sáanchez-Beato, Maria Elena Rodríguez, Cristina Gómez Abad, Raquel Villuendas, Manuela Mollejo, Miguel A. Martínez, Javier Menarguez, Andrea Diaz-Alderete, Juana Gil, Juan Cigudosa, David G. Pisano, Miguel A. Piris, Nerea Martínez
Journal: Blood (2009)
Adventures among Viruses
Authors: Christopher Howard Andrewes
Journal: New England Journal of Medicine (1950)

ON A wind-swept hilltop just outside Salisbury, in southern England, stands Harvard hospital, the site of the Common Cold Research Unit. I should like to tell you today how we are attempting there to learn something about the common cold, and also why we are doing it there, why we call the place Harvard hospital and what we have learned so far. I shall also have much to say about what we don't know, and I shall discuss means by which the problem can, perhaps, be attacked.Most of you know why our unit is called Harvard hospital, for I . . .
Comparative Analysis on Cellular Components of Bone Marrow Microenvironment in Normal and Aberrant Hematopoiesis
Authors: Young-Ho Lee, Young-hee Kwon, Kyoujung Hwang, Hyunju Jun, Byungbae Park, Chan-Jeoung Park, Chan-Hee Yoon, Seongsoo Jang, Hyun-Sook Chi, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee
Journal: Blood (2011)
Flow Cytometry Assessment of CD34+ Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study
Authors: Riccardo Saccardi, Carmen Azqueta, Lara Ballerini, Etienne Baudoux, Simone Dal Pozzo, Gomez Susana, Gesine Kogler, Francesco Lanza, Manuele Ongari, Sergio Querol, Teja Falk Radke, Vanderson Rocha, Annalisa Ruggeri, Serena Urbani, Eliane Gluckman
Journal: Blood (2014)
Frequent Activating Somatic Alterations in T-Cell Receptor / NF-κb Signaling in Adult T-Cell Leukemia/Lymphoma
Authors: Keisuke Kataoka, Yasunobu Nagata, Akira Kitanaka, Yuichi Shiraishi, Jun-ichirou Yasunaga, Yasushi Totoki, Kenichi Chiba, Aiko Sato-Otsubo, Shinichi Kotani, Masashi Sanada, Hiroko Tanaka, Hiromichi Suzuki, Yusuke Sato, Yusuke Shiozawa, Tetsuichi Yoshizato, Kenichi Yoshida, Hideki Makishima, Guangyong Ma, Kisato Nosaka, Masakatsu Hishizawa, Hidehiro Itonaga, Yoshitaka Imaizumi, Wataru Munakata, Nakamura Hiromi, Natsuko Hama, Kotaro Shide, Yoko Kubuki, Tomonori Hidaka, Takuro Kameda, Tsuyoshi Nakamaki, Ken Ishiyama, Shuichi Miyawaki, Kensei Tobinai, Yasushi Miyazaki, Akifumi Takaori-Kondo, Toshiki Watanabe, Tatsuhiro Shibata, Masao Matsuoka, Satoru Miyano, Kazuya Shimoda, Seishi Ogawa
Journal: Blood (2015)
Phase 2A Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent Lymphoma
Authors: Martin Dreyling, David Cunningham, Krimo Bouabdallah, Sarit Assouline, Eric Van den Neste, Umberto Vitolo, Marius Giurescu, Silvia Mappa, Julia Grunert, Barrett H. Childs, Franck Morschhauser
Journal: Blood (2014)
Beacoppescalated Followed By Radiotherapy of Initial Bulk or Residual Disease in Advanced Stage Hodgkin Lymphoma: Long-Term Follow up of the HD9 and HD12 Trials of the German Hodgkin Study Group
Authors: Stefanie Kreissl, Bastian von Tresckow, Helen Goergen, Heinz Haverkamp, Stephanie Sasse, Volker Diehl, Andreas Engert, Peter Borchmann
Journal: Blood (2016)
Cytoplasmic Nucleophosmin (NPMc+) Mutations and FMS-Like Tyrosine Kinase 3 (Flt3) Internal Tandem Duplication (ITD) Mutations Cooperate to Cause Leukemia In a Mouse Model
Authors: Rachel E. Rau, Daniel Magoon, Emily McIntyre, Li Li, Sarah Greenblatt, David Huso, Pier Paolo Pandolfi, Donald Small, Patrick Brown
Journal: Blood (2010)
DNMT3A Mutation May Add Prognostic Value To Patients With Acute Myeloid Leukemia Of Intermediate Cytogenetic Risk Harboring a Favorable Genetic Profile Of NPM1, FLT3-ITD and CEBPA
Authors: Marta Pratcorona, Marina Díaz-Beyá, Meritxell Nomdedeu, Maria Rozman, Ruth M Risueño, Jordi Esteve
Journal: Blood (2013)
Clofarabine (CLO) Has Single Agent Activity in Relapsed and Refractory Non-Hodgkin Lymphoma (NHL) Including Rituximab (R)-Refractory Patients (pts).
Authors: Chadi Nabhan, Jacob David Bitran, Walter Fried, Angel G. Galvez, Laura Magid, Kathy Tolzien, Wendy Dewey, Parameswaran Venugopal
Journal: Blood (2009)
Deguelin, Selective Silencing of the NPM1 Mutant Protein, Induces Differentiation and Potentiates Apoptosis in Acute Myeloid Leukemia Cells Carrying NPM1 Mutation.
Authors: Sha Yi, Yan Chen, Lu Wen, Benping Zhang, Jing He, Guohui Cui, Lijing Yang, Jun Fang, Fei Zhao, Jie Zhao, Zichu Zhao
Journal: Blood (2012)
Circulating Exosomal microRNAs Are Prognostic Markers in Multiple Myeloma
Authors: Salomon Manier, Herve Avet-Loiseau, Federico Campigotto, Karma Salem, Daisy Huynh, Siobhan Glavey, Antonio Sacco, Aldo M Roccaro, Stephane Minvielle, Philippe Moreau, Thierry Facon, Xavier Leleu, Edie A. Weller, Irene M. Ghobrial
Journal: Blood (2015)
Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)
Authors: François Gaudet, Jennifer F Nemeth, Ronan McDaid, Yingzhe Li, Benjamin Harman, Hillary Millar, Alexey Teplyakov, John Wheeler, Jinquan Luo, Susan Tam, Sheng-Jiun Wu, Emily Chen, Stephen Rudnick, Gerald Chu, Anna Hughes, Leopoldo Luistro, Diana Chin, Alexander Babich, Anna Kalota, Indrajeet Singh, Mark Salvati, Yusri Elsayed, Ricardo M. Attar
Journal: Blood (2016)
A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control
Authors: Hien K. Duong, Debbie Bates, Lisa A. Rybicki, Matt Kalaycio, Andresen Steven, Ronald Sobecks, Lisa Gallagher, Robert M Dean, Brian T. Hill, Donna M Abounader, Melissa Yurch, Christina Ferraro, Shawnda Tench, Kelly Cherni, Gina Green, Joseph Kohuth, Vanessa Farrow, Heather Koniarczyk, Shannon Jarancik, Linda McLellan, Jane Dabney, Brad Pohlman, Brian J. Bolwell
Journal: Blood (2013)
JAK2 Gene Is Mutated in Patients with Myeloproliferative Disorders and Spontaneous Erythroid Colony Formation but Not in Patients with Spontaneous Megakaryocyte Growth Only.
Authors: Satu Mustjoki, Ioana Borze, Riitta Alitalo, Sakari Knuutila, Eeva Juvonen
Journal: Blood (2006)
Response Rate of 16% and High Incidence of Adverse Events In Placebo-Treated Patients with CD25 Assay-Positive Cutaneous T-Cell Lymphoma (CTCL): An Analysis of Patient Characteristics and Predictors of Response
Authors: Miles Prince, Madeleine Duvic, Ann Martin, Wolfram Sterry, Chalid Assaf, David Straus
Journal: Blood (2010)
The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer
Authors: Michela Pasello, Anna Maria Giudice, Katia Scotlandi
Journal: Seminars in Cancer Biology (2019)

Overexpression of ATP-binding cassette (ABC) transporters is a cause of drug resistance in a plethora of tumors. More recent evidence indicates additional contribution of these transporters to other processes, such as tumor cell dissemination and metastasis, thereby extending their possible roles in tumor progression. While the role of some ABC transporters, such as ABCB1, ABCC1 and ABCG2, in multidrug resistance is well documented, the mechanisms by which ABC transporters affect the proliferation, differentiation, migration and invasion of cancer cells are still poorly defined and are frequently controversial. This review, summarizes recent advances that highlight the role of subfamily A members in cancer. Emerging evidence highlights the potential value of ABCA members as biomarkers of risk and response in different tumors, but information is disperse and very little is known about their possible mechanisms of action. The only clear evidence is that ABCA members are involved in lipid metabolism and homeostasis. In particular, the relationship between ABCA1 and cholesterol is becoming evident in different fields of biology, including cancer. In parallel, emerging findings indicate that cholesterol, the main component of cell membranes, can influence many physiological and pathological processes, including cell migration, cancer progression and metastasis. This review aims to link the dispersed knowledge regarding the relationship of ABCA members with lipid metabolism and cancer in an effort to stimulate and guide readers to areas that the writers consider to have significant impact and relevant potentialities.
A Novel Paradigm In Stem Cell Trafficking: The Ratio of Peripheral Blood Sphingosine-1 Phosphate (S1P) to Bone Marrow Ceramide-1 Phosphate (C1P) Regulates Mobilization and Homing of Hematopoietic Stem Cells
Authors: Chihwa Kim, Wu Wan, Rui Liu, Magdalena Kucia, Mary J. Laughlin, Janina Ratajczak, Mariusz Z Ratajczak
Journal: Blood (2010)
IκB Kinase Overcomes PI3K to Control FoxO3a Subcellular Localization in Acute Myeloid Leukemia.
Authors: Nicolas Chapuis, Sophie Park, Laurent Leotoing, Jerome Tamburini, Frederique Verdier, Valérie Bardet, Alexa Samantha Green, Fabrice Agou, Georges Bismuth, Veronique Baud, Patrick Mayeux, Catherine Lacombe, Didier Bouscary
Journal: Blood (2009)
External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans
Authors: Neela K Kumar, Erin R Weeda, Philip S Wells, Frank Peacock, Gregory J Fermann, Li Wang, Onur Baser, Jeff Schein, Crivera Crivera, Craig I Coleman, Christine G Kohn
Journal: Blood (2016)
Impact of High Body Surface Area on AML Outcome in Younger Patients: A Goelams Study
Authors: Xavier Cahu, Martin Carre, Christian Recher, Emmanuel Gyan, Jean-Francois Hamel, Arnaud Pigneux, Norbert Vey, Philippe Guardiola, Jacques Delaunay, Eric Jourdan, Bruno Lioure, Marie-Christine Bene, Norbert Ifrah, Jean-Yves Cahn
Journal: Blood (2014)
Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas
Authors: Aine McCarthy, Andrew James Clear, Jacek Marzec, Rita Coutinho, Robert D. Petty, Janet Matthews, Andrew Wilson, Sameena Iqbal, Maria Calaminici, John G. Gribben, Li Jia
Journal: Blood (2014)
Abstract #LB-5: Increased expression of phospho-Met (Tyr1349) is found in Non-Small Cell Lung Cancer metastases
Authors: Julia Carter, Larry Douglass, James Deddens, Bruce Colligan, Jackson Pemberton, Allison Foertsch, Diana Nardini, Denise Lucas, Jonathan Yingling, Wei Jennifer Yang, Jeremy Graff
Journal: Cancer Research (2009)

Growth factor receptors are important in lung cancer growth and progression and are potential targets for non-small cell lung cancer (NSCLC) therapy. c-Met, which is overexpressed in many cancers, is a tyrosine kinase receptor activated by binding to its ligand, hepatocyte growth factor (HGF). Receptor phosphorylation occurs at multiple tyrosines and leads to multiple biological responses including cell proliferation, motility, angiogenesis and morphogenesis. Our objective was an immunohistochemical study of c-Met and phospho-Met (p-Met)(Y1349) expression in clinical specimens of NSCLC. While expression of p-Met (Y1003) and (Y1230/1234/1235) has been reported in lung cancer, to our knowledge this is the first study of p-Met (Y1349) expression in NSCLC or other solid human tumors. Archived FFPE tissues from 52 lung cancer patients that underwent surgery at St. Elizabeth Medical Center between 1986 and 2000 were stained. Expression of c-Met and p-Met was evaluated semi-quantitatively for stain intensity and % of tissue stained. Histoscores (intensity X area) were calculated for cytoplasmic and nuclear stain. Data were analyzed by the Least Squares Means with the Tukey-Kramer adjustment. Survival was determined by Kaplan-Meier statistics. 31/32 (97%) primary adenocarcinoma (AdCa) specimens and 29/31 (94%) primary squamous cell carcinoma (SCC) specimens had cytoplasmic/membranous c-Met histoscores (HSC) of 0.9 - >1.8; 24/35 (69%) AdCa and 23/35 (66%) SCC had p-Met HSC of 0.45 - >1.8. In 52 patients, average C-Met HSC > 1 was marginally related to reduced survival (p = 0.0970). Except in bronchial epithelium, c-Met and p-Met (Y1349) expression was less in normal lung components compared to NSCLC; the average c-Met HSC in primary NCLC was significantly higher than the average c-Met HSC of all lung components including bronchial epithelium (1.95 + 0.10 vs. 1.59 + 0.06, p = 0.0050). c-Met HSC was similar in 66 specimens of primary NSCLC and 24 lymph node metastases (1.96 + 0.08 vs. 1.79 + 0.17, p = 0.2487); however p-Met (Y1349) HSC was significantly higher in lymph node metastases than primary NSCLC (1.04 + 0.14 vs. 0.71 + 0.08, p = 0.0351) or the average of all normal lung components (0.75 + 0.05, p = 0.0455). Median p-Met HSC in 40 patients with primary tumors without metastases was 0.468 vs. 1.052 in lymph node metastases from 12 patients. The p-Met (Y1249) nuclear histoscore was also significantly higher in lymph node metastases (0.32 + 0.12 vs. 0.11 + 0.03, p = 0.0038). We conclude that c-Met is overexpressed in both AdCa and SCC and is marginally related to survival, and that c-Met phosphorylation at tyrosine 1349 is increased in NSCLC metastases.  Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr LB-5.
Alternative Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A Large RNA-Seq Data Analysis of Newly-Diagnosed Myeloma Patients
Authors: Naim Rashid, Stephane Minvielle, Florence Magrangeas, Mehmet Kemal Samur, Alice Clynen, Adam Sperling, Yu-Tzu Tai, Mariateresa Fulciniti, Paul G. Richardson, Michel Attal, Philippe Moreau, Kenneth C. Anderson, Giovanni Parmigiani, Hervé Avet-Loiseau, Nikhil C. Munshi
Journal: Blood (2014)
A Comparison of Outcomes Between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)
Authors: Matthew A. Kutny, Susan Geyer, Kristina M Laumann, John Gregory, Cheryl L. Willman, Wendy Stock, Richard A. Larson, Bayard L. Powell, James H. Feusner
Journal: Blood (2014)
Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma
Authors: Jin An, Ji‐Hyang Lee, Ha‐Kyeong Won, Yewon Kang, Woo‐Jung Song, Hyouk‐Soo Kwon, You Sook Cho, Hee‐Bom Moon, Tae‐Bum Kim
Journal: Allergy (2019)
Lenalidomide Treatment Enhances Immunological Synapse Formation of Cord Blood Natural Killer Cells with B Cells Derived From Chronic Lymphocytic Leukemia
Authors: Dongxia Xing, Alan G. Ramsay, Simon Robinson, Catherine M. Bollard, Nina Shah, Richard Champlin, John G. Gribben, Elizabeth J Shpall
Journal: Blood (2011)
Coagulation and Resuscitation Patterns Following Transfusion with Polymerized Hemoglobin Based Oxygen Carrier (HBOC-201) after Severe Hemorrhage in Swine.
Authors: Francoise Arnaud, Michael Hammett, Nora Philbin, Jennifer Rice, Frank Dong, Shannon Flournoy, Bruce Pearce, Richard McCarron, Daniel Freilich
Journal: Blood (2004)
Prognostic Analysis of Aberrant Somatic Hypermutation of RhoH in Diffuse Large B Cell Lymphoma.
Authors: Akira Katsumi, Junji Hiraga, Toshihiro Iwasaki, Akihiro Abe, Hitoshi Kiyoi, Tadashi Matsushita, Tomohiro Kinoshita, Tomoki Naoe
Journal: Blood (2006)
Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study
Authors: Andre Goy, Rajni Sinha, Michael E. Williams, Sevgi Kalayoglu Besisik, Johannes Drach, Radhakrishnan Ramchandren, Michael J. Robertson, Irit Avivi, Jacob M. Rowe, Raoul Herbrecht, Achiel Van Hoof, Miklos Egyed, Lei Zhang, Sherri Cicero, Tommy Fu, Thomas E. Witzig
Journal: Blood (2012)
Left Atrium Enlargement Is An Independent Predictor of Overall Mortality In Patients with Cardiac AL Amyloidosis.
Authors: Dania Mohty, Philippe Pibarot, Nicole Darodes, Benedict Tanguy, David Lavergne, Najmeddine Echahidi, Patrice Virot, Dominique Bordessoule, Arnaud Jaccard
Journal: Blood (2010)
Genetic Associations with Bortezomib Mediated Neuropathy in Multiple Myeloma.
Authors: Sophie L Corthals, David C Johnson, Yvonne de Knegt, Hartmut Goldschmidt, Henk Lokhorst, Stéphane Minvielle, Florence Magrangeas, Jean-Luc Harousseau, Brian G M Durie, Brian G Van Ness, Gareth J Morgan, Pieter Sonneveld, Hervé Avet Loiseau
Journal: Blood (2009)
Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches
Authors: Shirshendu Sinha, Morie Gertz, Martha Lacy, Angela Dispenzieri, Suzanne Hayman, Francis Buadi, David Dingli, Ivana Micallef, William Hogan, Dennis Gastineau, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood (2010)
The Potential Prognostic Markers for Myelodysplatic Syndromes Studied By Surface Plasmon Resonance Imaging and Mass Spectrometry
Authors: Leona Chrastinova, Ondrej Pastva, Marketa Bockova, Pavel Sacha, Jiri Suttnar, Jana Stikarova, Alzbeta Hlavackova, Roman Kotlin, Jaroslav Cermak, Jiri Homola, Jan E. Dyr
Journal: Blood (2016)
Dose Interruption/Reduction Of Tyrosine Kinase Inhibitors In The First 3 Months Of Treatment of CML Is Associated With Inferior Early Molecular Responses and Predicts For An Increased Likelihood Of Discontinuation Of The 1st Line Agent
Authors: Jane F Apperley, Richard M Szydlo, Gareth Gerrard, James R McCue, Jamie Wardle, Richard E Clark, Stephen G O'Brien, Letizia Foroni
Journal: Blood (2013)
Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia
Authors: Athanasios Papadopoulos, George Ntaios, Georgia Kaiafa, Fotios I Girtovitis, Zoi Saouli, Zisis Kontoninas, Michael D. Diamantidis, Charalambos Andreadis, Christos Savopoulos, Apostolos Hatzitolios
Journal: Blood (2008)
Retrospective analysis for efficacy and safety of nivolumab in advanced gastric cancer patients with malignant ascites
Authors: Hirosumi Suzuki, Takeshi Yamada, Yuuya Hagiwara, Takafumi Ikeda, Yoshiki Komatsu, Yoshitaka Tange, Yutaro Sugiyama, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Ichinosuke Hyodo
Journal: Annals of Oncology (2019)
Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure - Data from a Large Tertiary Center in India
Authors: Chaitanya Krishna Puligundla, Sadashivudu Gundeti, Stalin Bala, Ashok Pillai, Praveen Adusumilli, Madhav Danthala, Meher Lakshmi Konatam, Lakshmi Srinivas Maddali
Journal: Blood (2016)
Post Tandem Autologous Stem Cell Transplant Maintenance Therapy with Bortezomib Improves Remission Duration and Quality of Response in Multiple Myeloma Patients.
Authors: Rosa Greco, Benedetto Ronci, Barbara Anaclerico, Velia Bongarzoni, Fulvio Pauselli, Piero Iacovino, Francesca Monardo, Giuseppe Avvisati, Luciana Annino
Journal: Blood (2009)
Interim or End of Treatment FGD-PET Complete Response Does Not Have Adequate Predictive Value in Mature T/NK Cell Lymphoma
Authors: Tatyana Feldman, Larysa Sanchez, Patrick Toth, David Panush, Lori A Leslie, Alan P Skarbnik, Anthony R. Mato, Kar Fai Chow, Ricardo Parrondo, Veronica Mariotti, Sejal Kothadia, Zhen Wang, Miguel Gonzalez, Pritish K. Bhattacharyya, Xiao Yang, Themba Nyirenda, Ewelina Protomastro, Lori A. Leslie, Andre Goy
Journal: Blood (2016)
Incidence of Silent Thrombosis in Myeloproliferative Neoplasm Patients below 60 Years : Single Center Egyptian Study
Authors: Mervat Mattar, Sahar Nassef, Noha M El Husseiny, Mohamed Abdel Kader Morad, Marwa Salah, Mohamed Roshdy El Masry, Ahmed Abdul Gawad
Journal: Blood (2018)
Contribution of Imaging Flow Cytometry to Storage Lesion Assessment: Identification of a Sub-Population of Morphologically Altered Erythrocytes
Authors: Pascal Amireault, Camille A Roussel, Michaël Dussiot, Mickael Marin, Alexandre Morel, Papa Alioune Ndour, Julien Duez, Caroline Le Van Kim, Olivier Hermine, Yves Colin-Aronovicz, Pierre A Buffet
Journal: Blood (2015)
Macrolide Antibiotics Block Autophagy Flux and Sensitize to Bortezomib Via Endoplasmic Reticulum-Stress-Mediated CHOP Induction in Myeloma Cells
Authors: Shota Moriya, Xiao-Fang Che, Seiichiro Komatsu, Akihisa Abe, Tomohiro Kawaguchi, Akihiko Gotoh, Masato Inazu, Akio Tomoda, Keisuke Miyazawa
Journal: Blood (2012)
G6PC3 Deficiency Associated with Congenital Neutropenia and Enterocolitis
Authors: Jana Diestelhorst, Daniel Kotlarz, Giridharan Appaswamy, Rita Beier, Peter M Krawitz, Peter N Robinson, Jochen Hecht, Jacek Puchalka, Alejandro A. Schäffer, Dietmar Pfeifer, Ulrich Baumann, Eva-Doreen Pfister, Gudrun Brandes, Gabriella Palla, Roland Jacobs, Hans H. Kreipe, Stefan Mundlos, Christoph Klein
Journal: Blood (2011)